Role of Telemedicine and Telegenetics Framework for the Management of Cancer Patients During the COVID-19 Pandemic

Abstract

After the outbreak of 2019 novel coronavirus infection (2019-nCoV), the disease has been regarded as an extremely fast-spreading respiratory tract infection causing mortality worldwide. It appears that patients with life-threatening tumors or immunosuppressed patients are at a greater risk of developing more severe symptoms induced by COVID-19. Thus, all patients should be provided with reliable consults and clinical treatment. The emergence of lockdown situations in more countries has motivated all governments, healthcare services, and customers to further use on-line strategies in different areas with full access to healthcare. Telecommunications are beginning to be used in healthcare systems with the aim of providing a tailor specific approach to disease management. During the COVID-19 pandemic, antiviral drugs have failed to treat the disease, and no vaccine has been developed for the disease due to the pleiotropy and complexity of 2019-nCoV. Genome-base investigations have brought new insights for the development of drugs to diagnose COVID-19 and predict its severity. In this review paper, we proposed a broad framework and interdisciplinary of telemedicine and genomic information for better management of patients and medical care professionals at different locations. By using a global telehealth network, patients can be analyzed in a shorter time with lower costs, and better plans can be developed for the management of patients based on genetic profiles in different populations.